Sign in

CIK 0001055726

  • Non-accelerated filer
  • Smaller reporting company

INOVIO PHARMACEUTICALS, INC.

Sign in to watch
Ticker
INO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330969592
Phone
+1 858-410-3134
Business address
660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462
Former names
INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
  1. 4 Open-market sale Director sold 3,045 shares at $6.62 ($20,158)
  2. 4 Option exercise Director acquired 8,700 shares (option exercise)
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 4 Open-market sale CFO sold 10,000 shares at $8.52 ($85,200)
  6. 4 Open-market sale Director sold 26,583 shares at an average $8.57 ($227,694)
  7. 4 Open-market sale Director sold 2,000 shares at $8.75 ($17,500)
  8. 4 Open-market sale Chief Operating Officer sold 4,710 shares at $8.97 ($42,249)
  9. 4 Option exercise Director acquired 4,274 shares (option exercise)
  10. 4 Open-market sale Director sold 2,000 shares at $10.41 ($20,820)
  11. 4 Shares withheld for taxes CFO gave up 31,410 shares (to pay taxes)
  12. 4 Shares withheld for taxes Chief Scientific Officer gave up 25,967 shares (to pay taxes)
  13. 4 Option exercise Director acquired 11,667 shares (option exercise)
  14. 4 Shares withheld for taxes Chief Executive Officer gave up 74,545 shares (to pay taxes)
  15. 4 Open-market sale Chief Operating Officer sold 16,881 shares at $10.06 ($169,823)
  16. 4 Shares withheld for taxes Chief Executive Officer gave up 98,297 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief Scientific Officer gave up 16,514 shares (to pay taxes)
  18. 4 Open-market sale Director sold 7,000 shares at an average $9.39 ($65,736)
  19. 4 Shares withheld for taxes CFO gave up 25,862 shares (to pay taxes)
  20. 4 Derivatives Options or other derivatives

Page 8 of 30 · 592 filings